Research Topics
Genomes and GenesSpecies | Marry M van den Heuvel-EibrinkSummaryAffiliation: Erasmus MC Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patientsBronno van der Holt
Department of Trials and Statistics HOVON Dutch Belgian Hemato Oncology Cooperative Group Data Center, Erasmus MC Daniel den Hoed Cancer Center and Sophia Children s Hospital, Rotterdam, The Netherlands
Clin Pharmacol Ther 80:427-39. 2006....
Characteristics and survival of 750 children diagnosed with a renal tumor in the first seven months of life: A collaborative study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms tumor study groupsMarry M van den Heuvel-Eibrink
Department of Pediatric Oncology Hematology Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 50:1130-4. 2008..To review the clinical characteristics and survival of infants diagnosed with a primary renal tumor in the first 7 months of life...
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemiaIris H I M Hollink
Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Haematologica 96:384-92. 2011..Our objective was to investigate the characteristics, gene expression profiles and prognostic impact of the different CEBPA aberrations in pediatric acute myeloid leukemia...
Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study groupMarry M van den Heuvel-Eibrink
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 56:733-7. 2011..Survival data of malignant rhabdoid tumour of the kidney (MRTK) registered in SIOP trials, advocating preoperative chemotherapy, are not available...
Sudden death due to pulmonary embolism as presenting symptom of renal tumorsM M van den Heuvel-Eibrink
Department of Pediatric Oncology Hematology, ErasmusMC Sophia Children s Hospital, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
Pediatr Blood Cancer 50:1062-4. 2008..This report describes two recent cases of sudden death in patients with renal tumors in which a fatal pulmonary embolus was the first presentation...
Paroxysmal nocturnal hemoglobinuria in childrenMarry M van den Heuvel-Eibrink
Department of Pediatric Oncology Hematology, Erasmus Medical Center Sophia Children s Hospital, Rotterdam, The Netherlands
Paediatr Drugs 9:11-6. 2007..This article reviews the reported cases of PNH in children using the recently published guidelines for classification, diagnostics, and treatment...
Childhood paroxysmal nocturnal haemoglobinuria (PNH), a report of 11 cases in the NetherlandsM M van den Heuvel-Eibrink
Erasmus Medical Centre Sophia Children s Hospital, 3015 GJ Rotterdam, The Netherlands
Br J Haematol 128:571-7. 2005..PNH, diagnosed by immunophenotypic GPI-linked anchor protein analysis, should be considered in all children with AA or MDS. BMT should be considered as a therapeutic option in every paediatric PNH patient with BM failure...
Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy onlyRobert D van Beek
Department of Pediatric Oncology Hematology, Erasmus Medical Center Sophia Children s Hospital, Rotterdam 3000 CB, The Netherlands
J Clin Endocrinol Metab 94:1904-9. 2009..The aim of this study was to investigate the long-term side effects of treatment for childhood Hodgkin's lymphoma with chemotherapy only on growth, bone mineral density (BMD), body composition, and thyroid function...
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemiaBrian V Balgobind
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Haematologica 96:1478-87. 2011..However, there has been no recent comprehensive overview of these genetic aberrations in one large pediatric acute myeloid leukemia cohort...
Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international studyEva A Coenen
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 117:7102-11. 2011..003) in univariate analysis only. In conclusion, like TP, specific ACAs have independent prognostic significance in pediatric 11q23/MLL-rearranged AML, and the mechanism underlying these prognostic differences should be studied...
Topotecan distribution in an anephric infant with therapy-resistant bilateral Wilms tumor with a novel germline WT1 gene mutationRieneke T Lugtenberg
Department of Pediatric Hematology Oncology, Erasmus MC Sophia Children s Hospital, Room Sp2568, P O Box 2060, 3000 CB Rotterdam, The Netherlands
Cancer Chemother Pharmacol 62:1039-44. 2008..This case showed a novel germline WT1 gene mutation of which the correlation with resistant phenotype has to be confirmed in larger cohorts of WT patients...
Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemiaMariel L te Winkel
Erasmus MC Sophia Children s Hospital, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
J Clin Oncol 29:4143-50. 2011..We studied cumulative incidence, risk factors, therapeutic strategies, and outcome of symptomatic osteonecrosis in pediatric patients with acute lymphoblastic leukemia (ALL)...
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicineCosta Bachas
Department of Pediatric Oncology Hematology, VU University Medical Center, Amsterdam, The Netherlands
Blood 116:2752-8. 2010..We hence propose that risk stratification, malignant cell detection, and selection of personalized treatment should be based on status of type I/II mutations both at initial diagnosis and during follow-up...
CBL mutations do not frequently occur in paediatric acute myeloid leukaemiaEva A Coenen
Department of Paediatric Oncology Haematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Br J Haematol 159:577-84. 2012..In conclusion, we report a very low CBL mutation frequency in paediatric AML, which, together with the lack of difference in protein and mRNA expression, illustrates the limited role of CBL in paediatric AML...
Adrenal function in adult long-term survivors of nephroblastoma and neuroblastomaMarjolein van Waas
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital Rotterdam, Dr Molewaterplein 60, Rotterdam, The Netherlands
Eur J Cancer 48:1159-66. 2012..Adrenal insufficiency, or relative insufficiency, might partly explain increased mortality rates in nephroblastoma and neuroblastoma survivors after unilateral adrenalectomy...
Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemiaAstrid A Danen-van Oorschot
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 58:715-21. 2012..Aberrant miRNA expression patterns have been found in various types of cancer. So far, information about the expression of miRNAs in pediatric acute myeloid leukemia is limited...
Low frequency of MLL-partial tandem duplications in paediatric acute myeloid leukaemia using MLPA as a novel DNA screenings techniqueBrian V Balgobind
Paediatric Oncology Haematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Eur J Cancer 46:1892-9. 2010..Larger prospective studies are needed to further define the prognostic relevance of MLL-PTD in paediatric AML...
High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23)Jenny E Kuipers
Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 117:928-35. 2011..70 vs 0.37, P = .03) In conclusion, we identified IGSF4 overexpression to be discriminative for t(9;11)(p22;q23) patients with FAB-M5, regulated partially by promoter methylation and resulting in survival benefit...
Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemiaMariel L te Winkel
Department of Pediatric Oncology Hematology, Erasmus MC, Sophia Children s Hospital, 3015 GJ Rotterdam, The Netherlands
Haematologica 95:752-9. 2010..This study investigates pharmacogenetic risk factors for bone mineral (apparent) density (BM(A)D) and body composition in pediatric acute lymphoblastic leukemia..
Management of adults with Wilms' tumor: recommendations based on international consensusHeidi Segers
Deptartment of Oncology Hematology, Erasmus MC Sophia Children s Hospital, Dr Molewaterplein, 603015 GJ, Rotterdam, The Netherlands
Expert Rev Anticancer Ther 11:1105-13. 2011..They provide a critical evaluation of the current evidence for the management of adult Wilms' tumors and propose details of how current pediatric therapeutic guidelines could be adapted for use in adults...
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression patternIris H I M Hollink
Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 118:3645-56. 2011..Taken together, NUP98/NSD1 identifies a previously unrecognized group of young AML patients, with distinct characteristics and dismal prognosis, for whom new treatment strategies are urgently needed...
Effect of childhood cancer treatment on fertility markers in adult male long-term survivorsNiels J van Casteren
Department of Urology, Section of Andrology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Pediatr Blood Cancer 52:108-12. 2009..Although it is accepted that pediatric cancer treatment harbors a risk of gonadal damage, large cohort studies using up-to-date fertility markers are lacking...
CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older ageMarry M van den Heuvel-Eibrink
Department of Hematology, P O Erasmus MC, Dr Molewaterplein 40, 3015 GJ, Rotterdam, The Netherlands
Ann Hematol 86:329-37. 2007..When adjusted for other prognostic actors, only CD34-related MDR1/BCRP coexpression remained significantly associated with a lower CR rate (p = 0.03), thereby identifying a clinically resistant subgroup of elderly AML patients...
Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosisBrian V Balgobind
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 111:4322-8. 2008..NF1 inactivation may provide an additional proliferative signal toward the development of leukemia...
Cystic nephroma, cystic partially differentiated nephroblastoma and cystic Wilms' tumor in children: a spectrum with therapeutic dilemmasJoop van den Hoek
Department of Pediatric Urology, Erasmus MC, Sophia Children s Hospital, Rotterdam, The Netherlands
Urol Int 82:65-70. 2009..There are difficulties in differentiating the three types using imaging techniques. Therefore, controversies exist regarding the optimal treatment...
KIAA1524: A novel MLL translocation partner in acute myeloid leukemiaEva A Coenen
Department of Pediatric Oncology and Hematology, Sophia Children s Hospital, Rotterdam, The Netherlands
Leuk Res 35:133-5. 2011..KIAA1524 has never been related to hematologic malignancies before, and the current AML case is the first case in which an MLL-KIAA1524 fusion was described...
NUT midline carcinoma of the parotid gland with mesenchymal differentiationMichael A Den Bakker
Department of Pathology, Erasmus MC, 3000 CA Rotterdam, The Netherlands
Am J Surg Pathol 33:1253-8. 2009..The findings demonstrate the first case of NMC arising within salivary gland, and the first example of mesenchymal differentiation in this group of tumors...
Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivorsMarjolein van Waas
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital Rotterdam, Rotterdam, The Netherlands
PLoS ONE 7:e52237. 2012..Reports on metabolic syndrome in nephroblastoma and neuroblastoma survivors are scarce. Aim was to evaluate the occurrence of and the contribution of treatment regimens to the metabolic syndrome...
KCNQ1OT1 hypomethylation: a novel disguised genetic predisposition in sporadic pediatric adrenocortical tumors?Mark Wijnen
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 59:565-6. 2012..This represents a likely novel genetic predisposition in patients with adrenocortical tumors without clear phenotypic features of the Beckwith-Wiedemann syndrome...
Obesity is underestimated using body mass index and waist-hip ratio in long-term adult survivors of childhood cancerKarin Blijdorp
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
PLoS ONE 7:e43269. 2012..In this study longitudinal changes of BMI and body composition, as well as the value of BMI and waist-hip ratio representing obesity, were evaluated in adult childhood cancer survivors...
CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemiaMartine van Grotel
Department of Pediatric Oncology Hematology, Erasmus University Medical Center Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 51:737-40. 2008....
A longitudinal study using tibial ultrasonometry as a bone assessment technique in children with acute lymphoblastic leukaemiaMaarten H Lequin
Department of Paediatric Radiology, Sophia Children s Hospital, University Hospital, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands
Pediatr Radiol 33:162-7. 2003..Several longitudinal studies have shown contradictory results regarding the change in bone status in children with acute lymphoblastic leukaemia (ALL) using dual-energy X-ray absorptiometry as the bone assessment technique...
The metabolic syndrome in adult survivors of childhood cancer, a reviewMarjolein van Waas
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
J Pediatr Hematol Oncol 32:171-9. 2010..Accordingly, it is important to identify the predisposing factors of the metabolic syndrome in cohorts of survivors, to introduce medical interventions, and to subsequently decrease the risk of cerebrovascular and cardiovascular events...
Semen cryopreservation in pubertal boys before gonadotoxic treatment and the role of endocrinologic evaluation in predicting sperm yieldNiels J van Casteren
Department of Urology, Andrology Unit, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Fertil Steril 90:1119-25. 2008..To evaluate the feasibility of semen cryopreservation in pubertal boys before they receive gonadotoxic therapy and to identify which pretreatment parameters might predict successful cryopreservation...
Successful treatment of congenital acute myeloid leukemia (AML-M6) in a premature infantJoyce C A van Dongen
Department of Pediatric Oncology Hematology, Erasmus University, Rotterdam, The Netherlands
J Pediatr Hematol Oncol 31:853-4. 2009..After treatment with a sequential low-dose cytarabine after birth and full-dose AML treatment according to the MRC-12 protocol at the age of 2 months, she now is in continuous complete remission for 4 years...
Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemiaAndrica C H De Vries
ErasmusMC Sophia Children s Hospital, Department of Pediatric Hematology Oncology, Room Sp 2568, Dr Molewaterplein 60, 3015 GJ, Rotterdam, The Netherlands
Haematologica 92:1557-60. 2007..No evidence for constitutively activation of FLT3/FLT3L was found in JMML, indicating that FLT3 inhibitors are unlikely to be effective in JMML...
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective studyBrian V Balgobind
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 114:2489-96. 2009..Screening for these translocation partners is needed for accurate treatment stratification at diagnosis...
Osteoporosis in children with cancerInge M van der Sluis
Department of Pediatric Oncology Hematology, Erasmus Medical Center, Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 50:474-8; discussion 486. 2008..Therefore, optimizing peak bone mass is of clinical importance. Preventive and therapeutic strategies, such as calcium and vitamin D supplementation, physical activity and bisphosphonates, are considered...
Peripheral stem cell harvest using regular chemotherapy schedules in childhood cancerSaskia L Gooskens
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Transplant 16:758-65. 2012..The optimal moment for harvesting in different types of tumors was highly variable, although most consistent in patients diagnosed with Ewing's sarcoma or brain tumors and after cyclophosphamide priming...
A U-HPLC-ESI-MS/MS-based stable isotope dilution method for the detection and quantitation of methotrexate in plasmaEthan den Boer
Department of Clinical Chemistry, Erasmus MC, Sophia Children s Hospital, Erasmus MC, University Medical Centre Rotterdam, s Gravendijkwal, Rotterdam, The Netherlands
Ther Drug Monit 34:432-9. 2012..The authors aimed to develop a liquid chromatography, electrospray ionization, tandem mass spectrometry (LC-ESI-MS/MS)-based method to determine MTX in plasma for therapeutic drug monitoring and pharmacokinetic studies...
[An infant with sternal swelling]Naomi Ketharanathan
Erasmus MC Sophia Kinderziekenhuis, Rotterdam, afd Kindergeneeskunde, The Netherlands
Ned Tijdschr Geneeskd 156:A3981. 2012..Sternal tumours in childhood are rare and alarming. These can be differentiated into benign and malignant tumours. This differentiation is important for the prevention of unnecessary diagnostic testing...
Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemiaMariel L te Winkel
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Haematologica 93:1570-4. 2008....
Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP)Saskia L M Gooskens
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 55:369-73. 2010..In the current report, we describe the first small pediatric DFSP series, in which response to imatinib mesylate contributed to successful treatment outcome...
Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhoodRobert D van Beek
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Room Sp3435, PO Box 2060, 3000 CB Rotterdam, The Netherlands
Hum Reprod 22:3215-22. 2007....
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemiaIris H I M Hollink
Department of Pediatric Oncology Hematology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Blood 113:5951-60. 2009..001). Patients with both a WT1 mutation and a FLT3/ITD had a dismal prognosis (5-year pOS 21%). WT1 mutations occur at a significant rate in childhood AML and are a novel independent poor prognostic marker...
Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-upCoriene E Catsman-Berrevoets
Department of Pediatric Neurology, Erasmus MC Sophia Children s Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 53:1048-53. 2009..In general, the outcome of neurologic and behavioral symptoms is poor. Studies on quality of life (Qol) and recovery after very long-term follow-up of children with OMS are lacking...
No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemiaRobert D van Beek
Department of Pediatric Hematology/Oncology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
Pediatr Blood Cancer 46:88-93. 2006..BMAD was normal after CNS-irradiation. CONCLUSIONS: Long term survivors of ALL treated with prednisolone or dexamethasone containing regimens do not differ in height, BMD, or body composition...
Pediatric aggressive fibromatosis: a retrospective analysis of 13 patients and review of literatureSaskia Buitendijk
Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
Cancer 104:1090-9. 2005..Positive margins after surgery indicated a high risk for disease recurrence. Multicenter, prospective (randomized) trials will be necessary to clarify the role of adjuvant treatment for patients with pediatric AF...
Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner geneLaura J C M van Zutven
Department of Genetics, Centre for Biomedical Genetics, Erasmus MC, Rotterdam, The Netherlands
Genes Chromosomes Cancer 45:437-46. 2006..JARID1A, at 12p13, codes for retinoblastoma binding protein 2, a protein implicated in transcriptional regulation. This is the first report of JARID1A as a partner gene in leukemia...
High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy onlyMartine van Grotel
Department of Pediatric Oncology/Hematology, Erasmus University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands
Leuk Lymphoma 47:1504-10. 2006..Moreover, it illustrates that although cure of pediatric NLPHL is feasible with chemotherapy only, high dosages of cytotoxic drugs are necessary as salvage treatment in a relatively high proportion of patients after relapse...
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trialFranco Locatelli
Oncoematologia Pediatrica, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy
Blood 105:410-9. 2005..Disease recurrence remains the major cause of treatment failure. Outcome of UD-HSCT recipients is comparable to that of children receiving transplants from an HLA-identical sibling...
Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutationsChristian Flotho
Blood 111:966-7; author reply 967-8. 2008
Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemiaInge M van der Sluis
Division of Endocrinology and Oncology-Hematology, Department of Pediatrics, Sophia Children's Hospital Rotterdam, The Netherlands
J Pediatr 141:204-10. 2002..CONCLUSIONS: Children with ALL are at risk for osteopenia because of the disease itself and the intensive chemotherapy. Fracture rate increases substantially, not only during but also shortly after treatment...
Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy onlyAnnemieke I Buizer
Department of Pediatrics, VU University Medical Center, Amsterdam, The Netherlands
J Int Neuropsychol Soc 11:554-65. 2005..The results indicate that chemotherapy-induced central neurotoxicity in childhood ALL treatment is associated with higher order visuomotor control deficits. Girls appear to be particularly vulnerable...
Bone mineral density in childhood acute lymphoblastic leukemia (ALL) during and after treatmentInge M van der Sluis
Pediatr Blood Cancer 43:182-3; discussion 184. 2004
Direct X-ray radiogrammetry versus dual-energy X-ray absorptiometry: assessment of bone density in children treated for acute lymphoblastic leukaemia and growth hormone deficiencyRick R van Rijn
Department of Radiology, Academic Medical Centre Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam Zuid Oost, The Netherlands
Pediatr Radiol 36:227-32. 2006..In recent years interest in bone densitometry in children has increased...
Behavioral and educational limitations after chemotherapy for childhood acute lymphoblastic leukemia or Wilms tumorAnnemieke I Buizer
Department of Pediatric Hematology Oncology, VU University Medical Center, Amsterdam, Netherlands
Cancer 106:2067-75. 2006..In this study, children with ALL received central nervous system directed chemotherapy without cranial irradiation...
Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhoodRobert D van Beek
Department of Pediatric Hematology Oncology, Erasmus MC Rotterdam, The Netherlands
J Clin Endocrinol Metab 92:3869-74. 2007..The aim of this study was to evaluate the long-term effects of combination chemotherapy treatment for girls with Hodgkin's lymphoma (HL) on gonadal function using anti-Müllerian hormone (AMH) and inhibin B as ovarian reserve parameters...
Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopeniaAyami Yoshimi
Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Germany
Haematologica 92:397-400. 2007..Six patients subsequently received a transplant because of non-response, progression to advanced myelodysplastic syndrome or evolution of monosomy 7. Overall and failure-free survival rates at 3 years were 88% and 57%, respectively...
